Literature DB >> 6278815

Anderson-Fabry's disease: neuropathological and neurochemical investigation.

F Tagliavini, V Pietrini, F Gemignani, A Lechi, R Pallini, A Federico.   

Abstract

A clinical, neuropathological and neurochemical study of a case of Anderson-Fabry's disease is described. The clinical course mainly consisted of repeated ictus with major involvement of the CNS. The neuropathological examination is dominated by severe alterations in the cerebral vessels due to glycolipid deposits on the walls, with reduction or occlusion of the lumen. This is correlated with secondary ischaemic foci scattered throughout the cortex as well as through the white matter. In addition, the cells of the cerebral cortex, thalamus, basal ganglia, amygdala, cerebellar and olivary nuclei show a marked accumulation of lipofuscin. Biochemical examination reveals a threefold increase in galactolipids due to the specific alpha-galactosidase deficiency. Cholesterol is reduced secondarily to ischaemic myelin damage. Glycosaminoglycans uronic acid is increased in cytosol and membrane-bound fractions which could be related to reactive gliosis. Glycoprotein sugars show a decrease in N-acetyl-neuraminic acid and fucose as well as an increase in hexosamines and hexoses in membrane-bound fraction, while in cytosol fraction all sugars are increased. This suggests that the alpha-galactosidase deficiency can alter not only the glycolipid but also the glycoprotein metabolism, resulting in a higher presence of hexosamines and hexoses-rich glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278815     DOI: 10.1007/bf00690579

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  36 in total

1.  Fabry's disease. Primary diagnosis by electron microscopy.

Authors:  P F Schatzki; B Kipreos; J Payne
Journal:  Am J Surg Pathol       Date:  1979-06       Impact factor: 6.394

2.  Beta-glucuronidase activities in tumors of the nervous system.

Authors:  N ALLEN
Journal:  Neurology       Date:  1961-07       Impact factor: 9.910

3.  A SIMPLE AND ACCURATE MICROMETHOD FOR QUANTITATIVE DETERMINATION OF GANGLIOSIDE PATTERNS.

Authors:  K SUZUKI
Journal:  Life Sci (1962)       Date:  1964-11

4.  Method for the determination of hexosamines in tissues.

Authors:  N F BOAS
Journal:  J Biol Chem       Date:  1953-10       Impact factor: 5.157

5.  Fabry's disease with familial lymphedema of the lower limbs. Case report and family study.

Authors:  F Gemignani; V Pietrini; F Tagliavini; A Lechi; T M Neri; A Asinari; M Savi
Journal:  Eur Neurol       Date:  1979       Impact factor: 1.710

6.  Determination of gangliosides, glycoproteins, and glycosaminoglycans in brain tissue.

Authors:  E G Brunngraber; B D Brown; H Hof
Journal:  Clin Chim Acta       Date:  1971-04       Impact factor: 3.786

7.  Sphingoglycolipids in the nervous system in Fabry's disease.

Authors:  T Miyatake; T Ariga
Journal:  J Neurochem       Date:  1972-08       Impact factor: 5.372

8.  Type 2 GM1 gangliosidosis with long survival and neuronal ceroid lipofuscinosis.

Authors:  J A Lowden; J W Callahan; R A Gravel; M A Skomorowski; L Becker; J Groves
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

9.  Fabry's disease: alpha-galactosidase deficiency.

Authors:  J A Kint
Journal:  Science       Date:  1970-02-27       Impact factor: 47.728

10.  Storage of lipofuscin in neurons in mucopolysaccharidosis. Report on a case of Sanfilippo's syndrome with histochemical and electron-microscopic findings.

Authors:  A Oldfors; P Sourander
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

View more
  5 in total

1.  Detecting the effects of Fabry disease in the adult human brain with diffusion tensor imaging and fast bound-pool fraction imaging.

Authors:  Hunter R Underhill; Katie Golden-Grant; Lauren T Garrett; Stefanie Uhrich; Brandon A Zielinski; C Ronald Scott
Journal:  J Magn Reson Imaging       Date:  2015-05-27       Impact factor: 4.813

2.  Leptomeningeal lipid storage patterns in Fabry disease.

Authors:  M Elleder; H Christomanou; B Kustermann-Kuhn; K Harzer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

3.  Fabry Disease With Concomitant Lewy Body Disease.

Authors:  Kelly Del Tredici; Albert C Ludolph; Simone Feldengut; Christian Jacob; Heinz Reichmann; Jürgen R Bohl; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2020-04-01       Impact factor: 3.685

4.  Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice.

Authors:  Michael P Nelson; Tonia E Tse; Darrel B O'Quinn; Stefanie M Percival; Edgar A Jaimes; David G Warnock; John J Shacka
Journal:  Acta Neuropathol Commun       Date:  2014-02-14       Impact factor: 7.801

5.  Altered Gene Expression in Prefrontal Cortex of a Fabry Disease Mouse Model.

Authors:  Kai K Kummer; Theodora Kalpachidou; Miodrag Mitrić; Michiel Langeslag; Michaela Kress
Journal:  Front Mol Neurosci       Date:  2018-06-25       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.